Related Experiment Video
Updated: Sep 9, 2025

Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos
Published on: September 9, 2015
Amoebic Liver Abscesses in Returning Travelers: Lessons to Keep in Mind From a Nonendemic Area
Anna Barbiero1, Sasha Trevisan1, Tommaso Manciulli1
1Experimental and Clinical Medicine Department, University of Florence, Florence, Italy.
Abstract:
Despite being relatively common in endemic settings, amoebic liver abscesses are rarely diagnosed in high-resource countries, where they are usually imported by migrants or travelers to endemic areas. Between 2010 and 2024, we observed two cases of amoebic liver abscess that were successfully managed in a tertiary-care center in Italy. In both cases, the infection was contracted in Colombia. Given the high morbidity and mortality associated with nontreated amoebic liver abscesses, this report aims at underlying the importance of travel history and of considering amoebic liver abscess among the differential diagnoses for people coming from endemic countries with compatible clinical presentations. Prompt diagnosis and treatment are of paramount importance for favorable clinical outcomes.
More Related Videos
Related Concept Videos
Fungal Phylum Microsporidia
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Endocarditis II: Clinical Features of Infective Endocarditis
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

